IMMUNIC, INC. — Director's Dealing 2014

Apr 16, 2014

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: VITAL THERAPIES INC (VTL)
CIK: 0001280776
Period of Report: 2014-04-16

Reporting Person: Loewen Andrea (See Remarks)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Incentive Stock Option (right to buy)	$8.00	2023-07-15	Common Stock (12500)		Direct
Non-Qualified Stock Option (right to buy)	$8.00	2023-07-15	Common Stock (37675)		Direct

Footnotes

F1: This stock option was granted on July 15, 2013 and vests over four years. Subject to the optionee continuing to provide services, one forty-eighth of the shares subject to the option vest one month after the vesting commencement date of July 15, 2013, and an additional one forty-eighth of the shares vest at the end of each monthly period thereafter. The option is subject to an early exercise provision and is immediately exercisable.